Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Ovarian_Cancer
|
| gptkbp:affects |
gptkb:philosopher
|
| gptkbp:associated_with |
obesity
infertility insulin resistance acne hirsutism dark patches of skin male-pattern baldness skin tags |
| gptkbp:can_lead_to |
metabolic syndrome
high blood pressure sleep apnea gestational diabetes infertility issues cholesterol abnormalities |
| gptkbp:complications |
gptkb:hospital
endometrial cancer type 2 diabetes |
| gptkbp:diet |
gptkb:stadium
dietary changes |
| gptkbp:discovered_by |
gptkb:Irving_F._Stein_Jr.
|
| gptkbp:first_described_by |
gptkb:1935
|
| gptkbp:genetic_diversity |
multiple genes involved
|
| https://www.w3.org/2000/01/rdf-schema#label |
Polycystic ovary syndrome
|
| gptkbp:impact |
gptkb:historical_event
anxiety |
| gptkbp:is_popular_in |
5-10% of women of reproductive age
|
| gptkbp:managed_by |
gptkb:psychologist
gptkb:product gptkb:item healthcare provider gynecologist |
| gptkbp:risk_factor |
family history
high body mass index |
| gptkbp:social_responsibility |
ultrasound
NIH criteria Rotterdam criteria |
| gptkbp:symptoms |
excess androgen levels
irregular menstrual cycles polycystic ovaries |
| gptkbp:treatment |
gptkb:drug
gptkb:metformin lifestyle changes oral contraceptives hormonal therapy spironolactone clomiphene citrate |